• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞与骨关节炎:治疗手段还是帮凶?

Mesenchymal stem cells and osteoarthritis: remedy or accomplice?

机构信息

Regenerative Medicine Institute, National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Ireland.

出版信息

Hum Gene Ther. 2010 Oct;21(10):1239-50. doi: 10.1089/hum.2010.138.

DOI:10.1089/hum.2010.138
PMID:20649459
Abstract

Multipotent mesenchymal stromal or stem cells (MSCs) are likely to be agents of connective tissue homeostasis and repair. Because the hallmark of osteoarthritis (OA) is degeneration and failure to repair connective tissues it is compelling to think that these cells have a role to play in OA. Indeed, MSCs have been implicated in the pathogenesis of OA and, in turn, progression of the disease has been shown to be therapeutically modulated by MSCs. This review discusses current knowledge on the potential of both marrow- and local joint-derived MSCs in OA, the mode of action of the cells, and possible effects of the osteoarthritic niche on the function of MSCs. The use of stem cells for repair of isolated cartilage lesions and strategies for modulation of OA using local cell delivery are discussed as well as therapeutic options for the future to recruit and appropriately activate endogenous progenitors and/or locally systemically administered MSCs in the early stages of the disease. The use of gene therapy protocols, particularly as they pertain to modulation of inflammation associated with the osteoarthritic niche, offer an additional option in the treatment of this chronic disease. In summary, elucidation of the etiology of OA and development of technologies to detect early disease, allied to an increased understanding of the role MSCs in aging and OA, should lead to more targeted and efficacious treatments for this debilitating chronic disease in the future.

摘要

多能间充质基质或干细胞(MSCs)可能是结缔组织稳态和修复的介质。由于骨关节炎(OA)的标志是变性和结缔组织修复失败,因此认为这些细胞在 OA 中具有一定的作用。事实上,MSCs 已被牵连到 OA 的发病机制中,反过来,疾病的进展已被证明可以通过 MSCs 进行治疗调节。这篇综述讨论了骨髓和关节内源性 MSCs 在 OA 中的潜在作用、细胞的作用模式以及 OA 微环境对 MSCs 功能的可能影响。还讨论了使用干细胞修复孤立性软骨损伤以及使用局部细胞递送来调节 OA 的策略,以及未来在疾病早期招募和适当激活内源性祖细胞和/或局部全身给予 MSCs 的治疗选择。基因治疗方案的应用,特别是与调节与 OA 微环境相关的炎症相关的方案,为这种慢性疾病的治疗提供了另一种选择。总之,阐明 OA 的病因学和开发早期疾病检测技术,以及增加对 MSCs 在衰老和 OA 中作用的理解,应该会导致未来针对这种使人衰弱的慢性疾病更具针对性和更有效的治疗方法。

相似文献

1
Mesenchymal stem cells and osteoarthritis: remedy or accomplice?间充质干细胞与骨关节炎:治疗手段还是帮凶?
Hum Gene Ther. 2010 Oct;21(10):1239-50. doi: 10.1089/hum.2010.138.
2
Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis.基于间充质干细胞的治疗方法治疗骨关节炎的软骨缺损。
Mol Biol Rep. 2012 May;39(5):5683-9. doi: 10.1007/s11033-011-1376-z. Epub 2011 Dec 20.
3
[Mesenchymal stem cells and regenerative medicine: future perspectives in osteoarthritis].[间充质干细胞与再生医学:骨关节炎的未来展望]
Med Sci (Paris). 2018 Dec;34(12):1092-1099. doi: 10.1051/medsci/2018294. Epub 2019 Jan 9.
4
Modification of mesenchymal stem cells for cartilage-targeted therapy.间质干细胞的修饰用于软骨靶向治疗。
J Transl Med. 2022 Nov 8;20(1):515. doi: 10.1186/s12967-022-03726-8.
5
Mesenchymal stem cells genetically engineered to express platelet-derived growth factor and heme oxygenase-1 ameliorate osteoarthritis in a canine model.基因工程改造的间充质干细胞表达血小板衍生生长因子和血红素加氧酶-1可改善犬骨关节炎模型。
J Orthop Surg Res. 2021 Jan 11;16(1):43. doi: 10.1186/s13018-020-02178-4.
6
Detection of Repair of the Zone of Calcified Cartilage with Osteoarthritis through Mesenchymal Stem Cells by Ultrashort Echo Time Magnetic Resonance Imaging.通过超短回波时间磁共振成像检测骨关节炎中软骨钙化区的修复。
Chin Med J (Engl). 2018 May 5;131(9):1092-1098. doi: 10.4103/0366-6999.224725.
7
Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives.间充质干细胞用于骨关节炎炎症管理:现状与展望
Osteoarthritis Cartilage. 2015 Nov;23(11):2027-35. doi: 10.1016/j.joca.2015.07.004.
8
Mesenchymal stem cell secretome reduces pain and prevents cartilage damage in a murine osteoarthritis model.间充质干细胞分泌组减轻小鼠骨关节炎模型的疼痛并预防软骨损伤。
Eur Cell Mater. 2018 Nov 6;36:218-230. doi: 10.22203/eCM.v036a16.
9
Cartilage regeneration by selected chondrogenic clonal mesenchymal stem cells in the collagenase-induced monkey osteoarthritis model.在胶原酶诱导的猴骨关节炎模型中,通过选定的软骨形成克隆间充质干细胞进行软骨再生。
J Tissue Eng Regen Med. 2014 Nov;8(11):896-905. doi: 10.1002/term.1676. Epub 2013 Jan 21.
10
Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis.骨髓间充质干细胞归巢:机制还是随机?对关节炎靶向递送的影响。
Rheumatology (Oxford). 2015 Feb;54(2):210-8. doi: 10.1093/rheumatology/keu377. Epub 2014 Oct 6.

引用本文的文献

1
A bibliometric analysis of studies related to the nuclear factor kappa B signaling pathway in knee osteoarthritis between 2004 and 2023.2004年至2023年期间膝关节骨关节炎中与核因子κB信号通路相关研究的文献计量分析
Front Med (Lausanne). 2025 Jun 25;12:1572161. doi: 10.3389/fmed.2025.1572161. eCollection 2025.
2
Role of Autologous Micro-Fragmented Adipose Tissue in Osteoarthritis Treatment.自体微片段脂肪组织在骨关节炎治疗中的作用。
J Pers Med. 2024 Jun 6;14(6):604. doi: 10.3390/jpm14060604.
3
Women's contribution to stem cell research for osteoarthritis: an opinion paper.
女性对骨关节炎干细胞研究的贡献:一篇观点论文。
Front Cell Dev Biol. 2023 Dec 19;11:1209047. doi: 10.3389/fcell.2023.1209047. eCollection 2023.
4
Clinical phase I/II trial of SVF therapy for cartilage regeneration: A cellular therapy with novel 3D MRI imaging for evaluating chondral defect of knee osteoarthritis.用于软骨再生的SVF疗法的临床I/II期试验:一种采用新型3D磁共振成像评估膝骨关节炎软骨缺损的细胞疗法。
Front Cell Dev Biol. 2023 Jan 19;11:1106279. doi: 10.3389/fcell.2023.1106279. eCollection 2023.
5
Second-Look Arthroscopic Findings and Clinical Outcomes after Adipose-Derived Regenerative Cell Injection in Knee Osteoarthritis.脂肪来源再生细胞注射治疗膝关节骨关节炎的关节镜下再检查结果和临床转归。
Clin Orthop Surg. 2022 Sep;14(3):377-385. doi: 10.4055/cios20312. Epub 2022 Feb 7.
6
Exposure to Inflammatory Mediators Affects the Differentiation of Mesenchymal Progenitors.暴露于炎症介质会影响间充质祖细胞的分化。
Front Bioeng Biotechnol. 2022 Jun 22;10:908507. doi: 10.3389/fbioe.2022.908507. eCollection 2022.
7
Ascorbic Acid and Iron Supplement Treatment Improves Stem Cell-Mediated Cartilage Regeneration in a Minipig Model.抗坏血酸和铁补充剂治疗可改善小型猪模型中的干细胞介导的软骨再生。
Am J Sports Med. 2021 Jun;49(7):1861-1870. doi: 10.1177/03635465211005754. Epub 2021 Apr 19.
8
Intra-articular injection of human umbilical cord mesenchymal stem cells ameliorates monosodium iodoacetate-induced osteoarthritis in rats by inhibiting cartilage degradation and inflammation.关节腔内注射人脐带间充质干细胞通过抑制软骨降解和炎症反应改善大鼠碘乙酸钠诱导的骨关节炎。
Bone Joint Res. 2021 Mar;10(3):226-236. doi: 10.1302/2046-3758.103.BJR-2020-0206.R2.
9
Second-look arthroscopic findings of cartilage and meniscus repair after injection of adipose-derived regenerative cells in knee osteoarthrits: Report of two cases.膝关节骨关节炎患者注射脂肪源性再生细胞后软骨和半月板修复的二次关节镜检查结果:2例报告
Regen Ther. 2019 Aug 24;11:212-216. doi: 10.1016/j.reth.2019.07.010. eCollection 2019 Dec.
10
Mechanical and Enzymatic Procedures to Isolate the Stromal Vascular Fraction From Adipose Tissue: Preliminary Results.从脂肪组织中分离基质血管成分的机械和酶促方法:初步结果。
Front Cell Dev Biol. 2019 Jun 7;7:88. doi: 10.3389/fcell.2019.00088. eCollection 2019.